Welcome to Research News, a feature dedicated to highlighting important research projects and articles about Pelvic Radiation Disease (PRD) – including its causes, prevalence and ways to predict, treat and manage it.
In these stressful times, when the NHS and cancer research are sorely challenged, it is more important than ever to keep PRD in the minds and hearts of funding bodies, researchers and health professionals.
A quick reminder that PRDA’s has a summary document on clinical guidance and patient information on managing the symptoms of PRD.
We are extremely grateful to Dr Tim Ward who has hosted our August 2020 and Jan 2021 Research News. Dr Tim Ward worked as a cancer research scientist at the Manchester Christie Hospital for 36 years, and retired after being treated with radiotherapy for prostate cancer. He developed an active interest in Pelvic Radiation Disease having had to undertake several treatments for its symptoms. He has recently stepped down as Scientific Consultant Advisor to the charity as and was formally a Trustee for 7 years.
If you have any suggestions for inclusion, such as research studies and articles, please email us at firstname.lastname@example.org.
Unfortunately we are not able to include all items that are submitted.
All article links from Research News can be found below.
Please be aware that the links below take you to the article abstracts, and that the full articles may be pay-walled and only accessible by people who work for institutions with journal subscriptions.
- Gastrointestinal symptoms of pelvic radiation disease (part 1): literature review
- Gastrointestinal symptoms of pelvic radiation disease (part 2): impact on patients and carers
- Pelvic radiation disease (part 3): identification, investigations, findings, and management
- Gastrointestinal symptoms of pelvic radiation disease (part 4): professional awareness and specialist support
- Long-term Consequences of Pelvic Irradiation: Toxicities, Challenges, and Therapeutic Opportunities with Pharmacologic Mitigators
- Life after Prostate Cancer Diagnosis
- “Is Radiotherapy the Devil’s Work?”.
- Randomised clinical trial of a gastrointestinal care bundle to reduce symptoms in patients with pelvic cancer undergoing chemoradiotherapy.
- A proposed tailored investigational algorithm for women treated for gynaecological cancer with long-term gastrointestinal consequences
- Bowel dysfunction in survivors of gynaecologic malignancies
- Prophylactic Faecalibacterium prausnitzii treatment prevents the acute breakdown of colonic epithelial barrier in a preclinical model of pelvic radiation disease
- Lumbosacral Plexopathy in Pelvic Radiotherapy: An Association not to be Neglected; A Systematic Review
Modified: 26th February 2021